10x Genomics, Inc. Share Price & Technical Analysis

TXG · $23.68 (-4.05%)

Healthcare / Health Information Services

AI Score 66 · Neutral

$23.68

-4.05%

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related

Price chart

Seasonality

May has 4 positive and 1 negative years (last 5 years shown)

8% return in May, 0% avg return in past 3 year May month.

42% return in 2026, -5% avg return in past 3 years.

Swipe sideways to see all months →

JanFebMarAprMayJunJulAugSepOctNovDecYr
2624%14%-5%2%8%42%
253%-26%-19%-5%14%21%17%7%-15%15%37%-11%39%
24-24%11%-20%-22%-15%-15%6%13%-4%-29%-2%-9%-110%
2325%1%16%-5%1%7%12%-17%-22%-14%24%30%58%
22-35%-17%-6%-37%9%-12%-12%-17%-12%-6%37%-7%-115%

Monthly return % by calendar month · historical pattern, not a forecast

AI snapshotScore 66/100

Neutral · Strong · Uptrend

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and single cell methylation kits. It also provides Visium platform, a spatial analysis platform that uses high density DNA arrays to encode the physical location of biological analytes within a sample. This platform includes HD WT panel gene expression, and HD 3' gene expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides. In addition, the company offers Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section without the need for conventional sequencing; and slides and reagents. Further, it provides various software products comprising Cell Ranger, a scRNA-seq processing pipeline in scientific literature; Loupe Browser, which enables intuitive single-cell, spatial, and multiomic data visualization; and Xenium Explorer that enables intuitive in situ data visualization, which allows researchers to explore subcellular gene expression, spatial organization, and tissue-scale patterns. The company serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

$2.61B

P/E ratio

52W high

$26.45

52W low

$8.31

Volume

37,98,904

Beta

2.05

Related stocks in Healthcare

Frequently asked questions

What is 10x Genomics, Inc. share price today?
10x Genomics, Inc. (TXG) last traded around $23.68 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does TXG have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for TXG. Download the app for real-time alerts.
How can I analyze 10x Genomics, Inc. stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro